Results 331 to 337 of about 477,806 (337)
Some of the next articles are maybe not open access.

Evaluating tertiary adrenal insufficiency in rheumatology patients on long‐term systemic glucocorticoid treatment

Clinical Endocrinology, 2020
Patients with rheumatic diseases are often treated with prolonged, high‐dose systemic glucocorticoids which can cause hypothalamic‐pituitary‐adrenal (HPA) axis suppression and development of tertiary adrenal insufficiency.
R. Sagar   +4 more
semanticscholar   +1 more source

Adrenal insufficiency in prednisolone-treated patients with polymyalgia rheumatica or giant cell arteritis-prevalence and clinical approach.

Rheumatology, 2020
OBJECTIVES Glucocorticoid treatment is fundamental in polymyalgia rheumatica (PMR) and giant cell arteritis (GCA), but carries a risk of glucocorticoid-induced adrenal insufficiency.
S. Borresen   +6 more
semanticscholar   +1 more source

Adrenal insufficiency

Nature Reviews Disease Primers, 2021
S. Hahner   +7 more
semanticscholar   +2 more sources

Etiology of primary adrenal insufficiency in children: a 29-year single-center experience

Journal of Pediatric Endocrinology & Metabolism (JPEM), 2019
Background Primary adrenal insufficiency (PAI) in children is a rare condition and potentially lethal. The clinical characteristics are non-specific. It may be manifested as a chronic condition or crisis.
Melati Wijaya   +7 more
semanticscholar   +1 more source

Iatrogenic adrenal insufficiency in adults

Nature Reviews Endocrinology
J. Martin-Grace   +3 more
semanticscholar   +1 more source

Adrenal insufficiency: physiology, clinical presentation and diagnostic challenges.

Clinica chimica acta; international journal of clinical chemistry, 2020
J. Martin-Grace   +3 more
semanticscholar   +1 more source

Adrenal crises in children with adrenal insufficiency: epidemiology and risk factors

European Journal of Pediatrics, 2019
O. Eyal   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy